Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
77°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amarin Corp ADR
(NQ:
AMRN
)
0.6286
+0.0136 (+2.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Amarin Corp ADR
< Previous
1
2
3
4
5
6
Next >
Amarin Urges Shareholders to Vote “Against” Sarissa’s Harmful Proposals at Upcoming General Meeting – IT HAS NO PLAN, NO NEW IDEAS AND AN UNDERQUALIFIED SLATE
February 17, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Urges Amarin Shareholders to Vote for Change and Remake Amarin for Shareholders
February 17, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Sarissa Capital Blasts Amarin’s Repeated False Statements; Clearly Amarin Will Say Anything to Keep Sarissa Off the Board
February 16, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Leading Independent Proxy Firm ISS Joins Glass Lewis in Recommending that Amarin Shareholders Vote “AGAINST” Sarissa’s Value-Destructive Proposals
February 16, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Clearly and Definitively Instructed Registrar to Accept ALL Submitted Proxy Cards
February 16, 2023
Sarissa Issued its False Release Hours After Receiving Confirmation That All Proxy Cards Were Being Accepted
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Uncovers That Amarin’s Registrar Had Not Been Instructed to Accept Blue Proxy Cards Even Though Legally Required to Do So
February 15, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Sarissa Capital Disappointed That Amarin Webcast Continues Board’s Defense of Poor Results and Lack of Accountability
February 14, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Leading Independent Proxy Advisory Firm Glass Lewis Recommends that Amarin Shareholders Vote “AGAINST” All of Sarissa’s Proposals
February 13, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Warns of Amarin’s Expensive Attempts to Switch Votes by Inundating Shareholders With White Proxy Cards
February 13, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Amarin Shareholders Invited to Webcast with Board and Management Team
February 13, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Does Not Believe Amarin Cares About Shareholders
February 09, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Amarin Mails Letter Highlighting Why Shareholders Should Vote on the WHITE Proxy Card “AGAINST” Sarissa’s Harmful Proposals
February 09, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Highlights Amarin’s Inaccurate and Misleading Statements
February 07, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts
February 06, 2023
Company Files Investor Presentation and Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE Proxy Card
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Highlights Amarin’s Disregard for Shareholder Interests and Urges Shareholders to Vote the BLUE Proxy Card for Change at Amarin
February 03, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Amarin Mails Letter to Shareholders Highlighting New Board and Superior Leadership
February 02, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Urges Amarin Shareholders to Vote the Blue Card by February 22 to Fix Amarin for the Benefit of Shareholders
February 01, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
January 31, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
January 27, 2023
Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Present at SVB Securities Global Biopharma Conference
January 27, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Responds to Inaccurate and Misleading Statement by Sarissa
January 19, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Calls Out Amarin’s Sham Board Refreshment
January 18, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
January 11, 2023
Highlights Significant Board Refreshment, Operational and Financial Improvements and Engagement with Sarissa Capital Management
From
Amarin Corporation plc
Via
GlobeNewswire
Sarissa Capital Submits Notice to Call a Special Meeting of Amarin Shareholders to Add Directors and Remove Chairman Per Wold-Olsen
January 10, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
January 10, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
January 10, 2023
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 14, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland
December 07, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin Announces VAZKEPA® (icosapent ethyl) Approved by the Therapeutic Goods Administration (TGA) in Australia
November 15, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
Amarin to Present at Jefferies London Healthcare Conference
November 09, 2022
From
Amarin Corporation plc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.